BCLPX
Price
$8.56
Change
+$0.01 (+0.12%)
Updated
Aug 15 closing price
Net Assets
4.85B
HMEAX
Price
$19.54
Change
-$0.01 (-0.05%)
Updated
Aug 15 closing price
Net Assets
1.14B
Interact to see
Advertisement

BCLPX vs HMEAX

Header iconBCLPX vs HMEAX Comparison
Open Charts BCLPX vs HMEAXBanner chart's image
BlackRock Event Driven Equity Inv C
Price$8.56
Change+$0.01 (+0.12%)
VolumeN/A
Net Assets4.85B
NexPoint Merger Arbitrage A
Price$19.54
Change-$0.01 (-0.05%)
VolumeN/A
Net Assets1.14B
BCLPX vs HMEAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BCLPX vs. HMEAX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCLPX is a Buy and HMEAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BCLPX has more cash in the bank: 4.85B vs. HMEAX (1.14B). HMEAX pays higher dividends than BCLPX: HMEAX (4.81) vs BCLPX (3.50). BCLPX was incepted earlier than HMEAX: BCLPX (18 years) vs HMEAX (9 years). HMEAX (2.74) is less costly to investors than BCLPX (2.37). HMEAX is a more actively managed with annual turnover of: 556.00 vs. BCLPX (32.00). BCLPX has a lower initial minimum investment than HMEAX: BCLPX (1000) vs HMEAX (2500). HMEAX annual gain was more profitable for investors over the last year : 5.32 vs. BCLPX (4.79). HMEAX return over 5 years is better than : 16.02 vs. BCLPX (10.40).
BCLPXHMEAXBCLPX / HMEAX
Total Expense Ratio2.282.4992%
Annual Report Gross Expense Ratio2.372.7486%
Fund Existence18 years9 years-
Gain YTD5.7833.500165%
Front LoadN/A6%-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets4.85B1.14B426%
Annual Yield % from dividends3.504.8173%
Returns for 1 year4.795.3290%
Returns for 3 years8.0414.7355%
Returns for 5 years10.4016.0265%
Returns for 10 years10.50N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBLL12.310.52
+4.41%
CERIBELL INC
ASND198.326.28
+3.27%
Ascendis Pharma A/S
REVB2.58N/A
N/A
Revelation Biosciences Inc
TRUP48.61-0.88
-1.78%
Trupanion
EXOZ9.70-0.29
-2.90%
eXoZymes Inc